These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Zhang W, Dai W, Zhang C, Zhou Y, Xiong P, Wang S, Ye X, Liu Q, Zhou D, Huang Z. Emerg Microbes Infect; 2018 May 18; 7(1):94. PubMed ID: 29777102 [Abstract] [Full Text] [Related]
8. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice. Sun S, Jiang L, Liang Z, Mao Q, Su W, Zhang H, Li X, Jin J, Xu L, Zhao D, Fan P, An D, Yang P, Lu J, Lv X, Sun B, Xu F, Kong W, Jiang C. Hum Vaccin Immunother; 2014 May 18; 10(10):2885-95. PubMed ID: 25483672 [Abstract] [Full Text] [Related]
10. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model. Qian SS, Wei ZN, Jin WP, Wu J, Zhou YP, Meng SL, Guo J, Wang ZJ, Shen S. Emerg Microbes Infect; 2021 Dec 18; 10(1):763-773. PubMed ID: 33739899 [Abstract] [Full Text] [Related]
11. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease. Lim H, In HJ, Lee JA, Sik Yoo J, Lee SW, Chung GT, Choi YK, Chung JK, Cho SJ, Lee JW. Vaccine; 2018 Jun 07; 36(24):3445-3452. PubMed ID: 29739716 [Abstract] [Full Text] [Related]
12. Coxsackievirus A6 Infection Causes Neurogenic Pathogenesis in a Neonatal Murine Model. Sun Q, Li J, Wang R, Sun T, Zong Y, Wang C, Liu Y, Li X, Song Y, Zhang Y. Viruses; 2023 Feb 12; 15(2):. PubMed ID: 36851724 [Abstract] [Full Text] [Related]
13. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease. Fang CY, Liu CC. Expert Rev Vaccines; 2018 Sep 12; 17(9):819-831. PubMed ID: 30095317 [Abstract] [Full Text] [Related]
14. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model. Jin WP, Lu J, Zhang XY, Wu J, Wei ZN, Mai JY, Qian SS, Yu YT, Meng SL, Wang ZJ, Shen S. J Virol; 2021 Feb 24; 95(6):. PubMed ID: 33408178 [Abstract] [Full Text] [Related]
15. A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6. Yang L, Mao Q, Li S, Gao F, Zhao H, Liu Y, Wan J, Ye X, Xia N, Cheng T, Liang Z. Antiviral Res; 2016 Oct 24; 134():50-57. PubMed ID: 27582066 [Abstract] [Full Text] [Related]
16. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model. Xu Y, Ma S, Zhu L, Huang Z, Chen L, Xu Y, Yin H, Peng T, Wang Y. Antiviral Res; 2017 Jan 24; 137():67-75. PubMed ID: 27864074 [Abstract] [Full Text] [Related]
18. A murine model of coxsackievirus A16 infection for anti-viral evaluation. Liu Q, Shi J, Huang X, Liu F, Cai Y, Lan K, Huang Z. Antiviral Res; 2014 May 24; 105():26-31. PubMed ID: 24583030 [Abstract] [Full Text] [Related]
19. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice. Zhao H, Li HY, Han JF, Deng YQ, Zhu SY, Li XF, Yang HQ, Li YX, Zhang Y, Qin ED, Chen R, Qin CF. Sci Rep; 2015 Jan 19; 5():7878. PubMed ID: 25597595 [Abstract] [Full Text] [Related]